Review on Coronavirus Disease 2019 Transmission, Diagnosis And treatment
Main Article Content
Abstract
COVID-19 is caused by SARS-CoV-2, which first appeared in Wuhan, Hubei Prvince, Central China, in December 2019 and has spread rapidly since then. Coronavirus Disease 2019 (COVID-19) is caused by an infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and has caused one of the largest global outbreaks in recent years, posing a serious threat to global public health. World Health Organization (WHO) declared a global health emergency on January 30, 2020. Despite global efforts to prevent SARS-CoV2 transmission by quarantining infected people and their family members, social distancing, and school closures, the spread of infection could not be stopped. The case fatality rate is estimated to range from 2 to 3%. Diagnosis is by demonstration of the virus in respiratory secretions by special molecular tests. Common laboratory findings include normal/ low white cell counts with elevated = C-reactive protein (CRP). The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Treatment is essentially supportive; role of antiviral agents is yet to be established
References
Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko.
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs. 2020; pp. 2–5.
Manoj Kumar, Souhaila Al Khodor.
Pathophysiology and Treatment Strategies for COVID-19. 2020; pp. 2–6.
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn.
Pathogenesis and Pulmonary Pathology in SARS-CoV-2 (COVID-19) Host Cell Invasion.
Acta Scientific Microbiology. 2020;3(11): pp. 1–2.
Subramanian Boopathi, Adolfo B. Poma, Ponmalai Kolandaivel.
Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral Drug Promises and Rule Out Against Its Treatment.
J Biomol Struct Dyn. 2020; pp. 1–10.
Elahe Seyed Hosseini, Narjes Riahi Kashani.
The Novel Coronavirus Disease-2019 (COVID-19): Mechanism of Action, Detection and Recent Therapeutic Strategies.
Elsevier Publication. 2020; Volume 551; pp. 1–9.
Zhu N, Zhang D, Wang W, et al.
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
New England Journal of Medicine. 2020;382(8):727–733.
Zhong NS, Zheng BJ, Li YM, et al.
Epidemiology and Cause of Severe Acute Respiratory Syndrome (SARS) in Guangdong, China.
The Lancet. 2003;362(9393):1353–1358.
Yuki K, Fujiogi M, Koutsogiannaki S.
COVID-19 Pathophysiology: A Review.
Clinical Immunology. 2020;215:108427.
Li Q, Guan X, Wu P, et al.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
New England Journal of Medicine. 2020;382:1199–1207.
Belouzard S, Millet JK, Licitra BN, et al.
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein.
Viruses. 2012;4:1011–1033.
Al-Tawfiq JA, Al-Homoud AH, Memish ZA.
Remdesivir as a Possible Therapeutic Option for COVID-19.
Travel Medicine and Infectious Disease. 2020;34:101615.
Campochiaro C, Della-Torre E, Cavalli G, et al.
Efficacy and Safety of Tocilizumab in Severe COVID-19 Patients: A Single-Centre Retrospective Cohort Study.
European Journal of Internal Medicine. 2020;76:43–49.
Chorin E, Dai M, Shulman E, et al.
The QT Interval in Patients with COVID-19 Treated with Hydroxychloroquine and Azithromycin.
Nature Medicine. 2020;26:808–809.
